+1 347 708 0418
This report studies the RNAi for Therapeutic market, covering market size for segment by type (siRNA, miRNA, etc.), by application (Cancer, Cardiovascular, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Alnylam Pharmaceuticals, Arbutus Biopharma (Tekmira), Arrowhead, Dicerna Pharmaceuticals, Mirna Therapeutics, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for RNAi for Therapeutic from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the RNAi for Therapeutic market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of RNAi for Therapeutic including:
Alnylam Pharmaceuticals
Arbutus Biopharma (Tekmira)
Arrowhead
Dicerna Pharmaceuticals
Mirna Therapeutics
Quark Pharmaceuticals
RXi Pharmaceuticals
Silence Therapeutics
Benitec Biopharma
miRagen Therapeutics
Sylentis
Gradalis
Sirnaomics
Silenseed
Market split by Type, can be divided into:
siRNA
miRNA
shRNA
Market split by Application, can be divided into:
Cancer
Cardiovascular
HBV
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 RNAi for Therapeutic Market Overview
1.1 RNAi for Therapeutic Definition
1.2 Global RNAi for Therapeutic Market Size Status and Outlook (2016-2030)
1.3 Global RNAi for Therapeutic Market Size Comparison by Region (2016-2030)
1.4 Global RNAi for Therapeutic Market Size Comparison by Type (2016-2030)
1.5 Global RNAi for Therapeutic Market Size Comparison by Application (2016-2030)
1.6 Global RNAi for Therapeutic Market Size Comparison by Sales Channel (2016-2030)
1.7 RNAi for Therapeutic Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 RNAi for Therapeutic Market Segment Analysis by Player
2.1 Global RNAi for Therapeutic Sales and Market Share by Player (2019-2021)
2.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2019-2021)
2.3 Global RNAi for Therapeutic Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 RNAi for Therapeutic Market Segment Analysis by Type
3.1 Global RNAi for Therapeutic Market by Type
3.1.1 siRNA
3.1.2 miRNA
3.1.3 shRNA
3.2 Global RNAi for Therapeutic Sales and Market Share by Type (2016-2021)
3.3 Global RNAi for Therapeutic Revenue and Market Share by Type (2016-2021)
3.4 Global RNAi for Therapeutic Average Price by Type (2016-2021)
3.5 Leading Players of RNAi for Therapeutic by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 RNAi for Therapeutic Market Segment Analysis by Application
4.1 Global RNAi for Therapeutic Market by Application
4.1.1 Cancer
4.1.2 Cardiovascular
4.1.3 HBV
4.1.4 Other
4.2 Global RNAi for Therapeutic Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of RNAi for Therapeutic by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 RNAi for Therapeutic Market Segment Analysis by Sales Channel
5.1 Global RNAi for Therapeutic Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global RNAi for Therapeutic Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 RNAi for Therapeutic Market Segment Analysis by Region
6.1 Global RNAi for Therapeutic Market Size and CAGR by Region (2016-2030)
6.2 Global RNAi for Therapeutic Sales and Market Share by Region (2016-2021)
6.3 Global RNAi for Therapeutic Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America RNAi for Therapeutic Market Share by Type
6.4.3 North America RNAi for Therapeutic Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe RNAi for Therapeutic Market Share by Type
6.5.3 Europe RNAi for Therapeutic Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific RNAi for Therapeutic Market Share by Type
6.6.3 Asia-Pacific RNAi for Therapeutic Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America RNAi for Therapeutic Market Share by Type
6.7.3 South America RNAi for Therapeutic Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa RNAi for Therapeutic Market Share by Type
6.8.3 Middle East & Africa RNAi for Therapeutic Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading RNAi for Therapeutic Players
7.1 Alnylam Pharmaceuticals
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Arbutus Biopharma (Tekmira)
7.3 Arrowhead
7.4 Dicerna Pharmaceuticals
7.5 Mirna Therapeutics
7.6 Quark Pharmaceuticals
7.7 RXi Pharmaceuticals
7.8 Silence Therapeutics
7.9 Benitec Biopharma
7.10 miRagen Therapeutics
7.11 Sylentis
7.12 Gradalis
7.13 Sirnaomics
7.14 Silenseed
Chapter 8 Upstream and Downstream Analysis of RNAi for Therapeutic
8.1 Industrial Chain of RNAi for Therapeutic
8.2 Upstream of RNAi for Therapeutic
8.3 Downstream of RNAi for Therapeutic
Chapter 9 Development Trend of RNAi for Therapeutic (2022-2030)
9.1 Global RNAi for Therapeutic Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure RNAi for Therapeutic Example
Figure Global RNAi for Therapeutic Revenue (Million $) Status and Outlook (2016-2030)
Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Region (2016-2030)
Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Type (2016-2030)
Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Application (2016-2030)
Figure Global RNAi for Therapeutic Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global RNAi for Therapeutic Sales by Player (2019-2021)
Table Global RNAi for Therapeutic Sales Market Share by Player (2019-2021)
Figure Global RNAi for Therapeutic Sales Market Share by Player in 2021
Table Global RNAi for Therapeutic Revenue (Million $) by Player (2019-2021)
Table Global RNAi for Therapeutic Revenue Market Share by Player (2019-2021)
Figure Global RNAi for Therapeutic Revenue Market Share by Player in 2021
Table Global RNAi for Therapeutic Average Price by Player (2019-2021)
Figure Global RNAi for Therapeutic Average Price by Player in 2021
Figure Global RNAi for Therapeutic Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global RNAi for Therapeutic Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of siRNA
Figure Global siRNA Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of miRNA
Figure Global miRNA Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of shRNA
Figure Global shRNA Revenue (Million $) and Growth Rate (2016-2021)
Table Global RNAi for Therapeutic Sales by Type (2016-2021)
Table Global RNAi for Therapeutic Sales Market Share by Type (2016-2021)
Figure Global RNAi for Therapeutic Sales Market Share by Type in 2021
Table Global RNAi for Therapeutic Revenue (Million $) by Type (2016-2021)
Table Global RNAi for Therapeutic Revenue Market Share by Type (2016-2021)
Figure Global RNAi for Therapeutic Revenue Market Share by Type in 2021
Table Global RNAi for Therapeutic Average Price by Type (2016-2021)
Figure Global RNAi for Therapeutic Average Price by Type in 2021
Table Leading Players of RNAi for Therapeutic by Type in 2021
Figure Example of Cancer
Figure Global RNAi for Therapeutic for Cancer Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Cardiovascular
Figure Global RNAi for Therapeutic for Cardiovascular Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of HBV
Figure Global RNAi for Therapeutic for HBV Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Other
Figure Global RNAi for Therapeutic for Other Revenue (Million $) and Growth Rate (2016-2021)
Table Global RNAi for Therapeutic Sales by Application (2016-2021)
Table Global RNAi for Therapeutic Sales Market Share by Application (2016-2021)
Figure Global RNAi for Therapeutic Sales Market Share by Application in 2021
Table Leading Consumers of RNAi for Therapeutic by Application in 2021
Figure Example of Direct Channel
Figure Global RNAi for Therapeutic for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global RNAi for Therapeutic for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global RNAi for Therapeutic Revenue by Sales Channel (2016-2021)
Table Global RNAi for Therapeutic Revenue Market Share by Sales Channel (2016-2021)
Figure Global RNAi for Therapeutic Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of RNAi for Therapeutic by Sales Channel in 2021
Table Global RNAi for Therapeutic Market Size and CAGR by Region (2016-2030)
Table Global RNAi for Therapeutic Sales by Region (2016-2021)
Table Global RNAi for Therapeutic Sales Market Share by Region (2016-2021)
Figure Global RNAi for Therapeutic Sales Market Share by Region in 2021
Table Global RNAi for Therapeutic Revenue (Million $) by Region (2016-2021)
Table Global RNAi for Therapeutic Revenue Market Share by Region (2016-2021)
Figure Global RNAi for Therapeutic Revenue Market Share by Region in 2021
Table North America RNAi for Therapeutic Sales by Country (2016-2021)
Figure North America RNAi for Therapeutic Sales Market Share by Country (2016-2021)
Table North America RNAi for Therapeutic Revenue by Country (2016-2021)
Figure North America RNAi for Therapeutic Revenue Market Share by Country (2016-2021)
Figure North America RNAi for Therapeutic Market Share by Type in 2021
Figure North America RNAi for Therapeutic Market Share by Application in 2021
Figure United States RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure United States RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Canada RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Mexico RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Table Europe RNAi for Therapeutic Sales by Country (2016-2021)
Figure Europe RNAi for Therapeutic Sales Market Share by Country (2016-2021)
Table Europe RNAi for Therapeutic Revenue by Country (2016-2021)
Figure Europe RNAi for Therapeutic Revenue Market Share by Country (2016-2021)
Figure Europe RNAi for Therapeutic Market Share by Type in 2021
Figure Europe RNAi for Therapeutic Market Share by Application in 2021
Figure Germany RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Germany RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure UK RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure UK RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure France RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure France RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Italy RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Russia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Spain RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific RNAi for Therapeutic Sales by Country (2016-2021)
Figure Asia-Pacific RNAi for Therapeutic Sales Market Share by Country (2016-2021)
Table Asia-Pacific RNAi for Therapeutic Revenue by Country (2016-2021)
Figure Asia-Pacific RNAi for Therapeutic Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific RNAi for Therapeutic Market Share by Type in 2021
Figure Asia-Pacific RNAi for Therapeutic Market Share by Application in 2021
Figure China RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure China RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Japan RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Korea RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure India RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure India RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Southeast Asia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Australia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Table South America RNAi for Therapeutic Sales by Country (2016-2021)
Figure South America RNAi for Therapeutic Sales Market Share by Country (2016-2021)
Table South America RNAi for Therapeutic Revenue by Country (2016-2021)
Figure South America RNAi for Therapeutic Revenue Market Share by Country (2016-2021)
Figure South America RNAi for Therapeutic Market Share by Type in 2021
Figure South America RNAi for Therapeutic Market Share by Application in 2021
Figure Brazil RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Brazil RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Argentina RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Colombia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa RNAi for Therapeutic Sales by Country (2016-2021)
Figure Middle East & Africa RNAi for Therapeutic Sales Market Share by Country (2016-2021)
Table Middle East & Africa RNAi for Therapeutic Revenue by Country (2016-2021)
Figure Middle East & Africa RNAi for Therapeutic Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa RNAi for Therapeutic Market Share by Type in 2021
Figure Middle East & Africa RNAi for Therapeutic Market Share by Application in 2021
Figure UAE RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure UAE RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure Saudi Arabia RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa RNAi for Therapeutic Sales and Growth Rate (2016-2021)
Figure South Africa RNAi for Therapeutic Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Alnylam Pharmaceuticals
Table RNAi for Therapeutic Introduction of Alnylam Pharmaceuticals
Table RNAi for Therapeutic Sales, Price, Revenue, Gross Margin and Market Share of Alnylam Pharmaceuticals (2019-2021)
Table Industrial Chain of RNAi for Therapeutic
Table Manufacturing Cost Structure of RNAi for Therapeutic
Table General Manufacturing Process of RNAi for Therapeutic
Table Leading Distributors/Dealers of RNAi for Therapeutic
Table Leading Consumers of RNAi for Therapeutic
Figure Global RNAi for Therapeutic Sales and Growth Rate Forecast (2022-2030)
Figure Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2022-2030)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Region (2022-2030)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Type (2022-2030)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Application (2022-2030)
Table Global RNAi for Therapeutic Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
